Advertisement

Topics

Celgene Cellular Therapeutics Company Profile

00:06 EST 19th November 2017 | BioPortfolio

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation.


News Articles [1262 Associated News Articles listed on BioPortfolio]

Nimbus Therapeutics, Celgene to develop autoimmune disorder programs

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, announced the initiation of a long-term strategic alliance with Celgene in...

Celgene exercises option to extend strategic collaboration scope and term with Forma Therapeutics

Forma Therapeutics and Celgene announced an innovative R&D partnership in 2014 to pursue ground-breaking medicines in oncology and other therapeutic areas.

Celgene & Juno Therapeutics announce landmark deal for CAR-T Cancer Therapies

Celgene and Juno Therapeutics have announced a decade long collaboration to advance potentially groundbreaking immunotherapies for patients with cancer and autoimmune diseases. The two companies will ...

Dragonfly, Celgene to collaborate on blood cancer therapy development

Dragonfly Therapeutics and Celgene will partner to cultivate new therapies for the treatment of hematologic cancers such as m -More- 

How Celgene Could Reap Huge Rewards From This Tiny Biotech

Celgene loves cozying up to emerging biotech stocks working on next-generation medicine, and one of those collaborations is with Jounce Therapeutics.

Celgene Broadens Forma Deal, Adding $195M More for Drug R&D

Celgene and Forma Therapeutics are expanding their already extensive relationship. The Summit, NJ-based drugmaker has exercised a $195 million option to widen the breadth of the 2014 deal it signed wi...

Juno nets $272.8mm in latest follow-on offering

Juno Therapeutics Inc. (cellular immunotherapies for cancer) netted $272.8mm through a public offering of 7mm common shares (including the overallotment) at $41. The company concurrently issued its pa...

License Agreement: Clovis Oncology $CLVS (Celgene, $CELG)

May 2010, $CLVS entered into an exclusive worldwide license agreement with Avila Therapeutics, Inc. (now Celgene Avilomics Research Inc., part of Celgene Corporation $CELG) to discover, develop and co...

PubMed Articles [1463 Associated PubMed Articles listed on BioPortfolio]

Celgene eyes 'inverse vaccines' in Anokion and Delinia deals.

Cellular therapies in trauma and critical care medicine: Looking towards the future.

Shibani Pati and Todd Rasmussen summarize progress in preclinical research on cellular therapeutics for traumatic injury and its sequelae and discuss prospects for clinical translation.

Self-assembling Lipid-Peptide Hybrid Nanoparticles of Phospholipid-Nonaarginine Conjugates for Enhanced Delivery of Nucleic Acid Therapeutics.

Despite potential applications of nucleic acid therapeutics, the lack of effective delivery systems hinders their clinical application. To overcome the barriers to nucleic acid delivery, we previously...

Ultrastructural characterization of the Mitochondria-associated membranes abnormalities in human astrocytomas: Functional and therapeutics implications.

Mitochondria-associated membranes (MAMs) are currently considered an intracellular organelle "hot spot" for the intracellular signaling. MAMs are thought to function in cellular energy homeostasis, ap...

Targeting ligand-receptor interactions for development of cancer therapeutics.

The biological importance and druggable properties of receptors and their cognate ligands have designated them as especially useful clinical targets. This significance continues to expand as new molec...

Clinical Trials [726 Associated Clinical Trials listed on BioPortfolio]

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Multi-center, survival data collection in subjects previously enrolled in Celgene Protocol CC-5013-MDS-003.

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Dendritic cell-based cellular vaccine for tumor therapy has shown efficacy. This study is designed to perform a personalized clinical trial by first analyzing the expression of tumor assoc...

Mitochondrial Bioenergetics and Role in Cellular Damage in Ischemic Myocardium

Cardiac ischemia is a common pathological condition, known to elicit multiple pathological processes at the cellular level. One of the most affected is thought to be cellular metabolism, k...

Companies [1488 Associated Companies listed on BioPortfolio]

Celgene Cellular Therapeutics

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. ...

Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. C...

Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics (PTI) is developing novel disease-modifying therapeutics that target the cellular pathways regulating protein folding, trafficking, and clearance. The Pr...

PTC Therapeutics, Inc.

PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes. Post-tra...

Celgene Corporation

Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and devel...

More Information about "Celgene Cellular Therapeutics" on BioPortfolio

We have published hundreds of Celgene Cellular Therapeutics news stories on BioPortfolio along with dozens of Celgene Cellular Therapeutics Clinical Trials and PubMed Articles about Celgene Cellular Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celgene Cellular Therapeutics Companies in our database. You can also find out about relevant Celgene Cellular Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record